1. Article › Research › Peer-reviewed

2. Economic evaluation of Tislelizumab Versus Chemotherapy as Second Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China

   Shi, F., He, Z., Su, H., Wang, L. & Han, S., 16 Nov 2022, In: Frontiers in Pharmacology. 13

   Research output: Contribution to journal › Article › peer-review